Leo Sher, M.D. Today, on Sunday, September 18, National Respect Day is celebrated in the U.S. Let’s reflect deeper about how we treat the people around us and make changes wherever necessary. A good place to start is by active listening and treating other people as we want to be treated. Let’s respectfully consider the […]
Steven Lippmann, M.D. Infectious diseases are big in the news nowadays: monkeypox is spreading worldwide, including in our country. This comes despite rising coronavirus numbers and now we also hear about acute hepatitis affecting children. What if you see a person that might have monkeypox? Here is a quick guide. Consider monkeypox currently if you […]
Steven Lippmann, M.D. The coronavirus pandemic caused us some hard times – disruption, devastation, and death. Despite a recent rise in COVID-19 disease incidence, there is a general feeling that the illness is diminishing. There are countermeasures to mitigate its severity: several vaccines, monoclonal antibody therapies, and antiviral agents. Vaccines can induce some immunity, monoclonal […]
Steven Lippmann, M.D. “Botox”, or botulinum toxin, has long had popular cosmetic use at smoothing facial wrinkles. It is also prescribed for pathologies, mostly of neuromuscular origins, like in pain syndromes and/or muscular spam cases. Many people like and benefit from the results. Researchers began noticing that injecting extracts from the bacterium Clostridium botulinum into […]
Leo Sher, M.D. My commentary, “Smoking enhances suicide risk-a significant role in the COVID-19 pandemic?” has recently been published in the QJM: An International Journal of Medicine (1). A summary of my article is below: The COVID-19 outbreak has severely affected the whole world. Considerable evidence suggests that tobacco smoking is associated with increased severity […]
Aya Allam, M.D., Steven Lippmann, M.D. We know lots about the current omicron spread. So, what is going on with this new antiviral drug, branded as Paxlovid and made by Pfizer? This pharmaceutical was just approved for early-on therapeutic prescribing to patients at high risk to SARS-Cov-2 virus infection yielding a serious COVID-19 disease. It […]
Leo Sher, M.D. Our review, “Suicide prevention in the covid-19 era” was published in Preventive Medicine online ahead of print on September 16, 2021 and included in the November 2021 print issue of the Journal (1). A summary of our article is below: The COVID-19 pandemic is affecting the health of people all around the […]
Aya Allam, M.D., Steven Lippmann, M.D. Early in the pandemic, then President Trump contracted a COVID-19 illness and took some medications to counter his illness. He survived. One of the drugs he received was remdesivir, an antiviral pharmaceutical. Now, more recently approved to counter coronavirus infections; what is there to know about remdesivir? Further back, […]
Amal Mumtaz, M.D., Steven Lippmann, M.D. Though improving slightly, we are still deep in the coronavirus pandemic. Beyond just being infected and getting sick or dying, there is considerable concern about short- and long-term sequela. Many of these involve neuropsychiatric manifestations. What are they? To start with, there is much general anxiety and uncertainty about […]
Aya Allam, M.D., Steven Lippmann, M.D. Besides all the pandemic talk these days, we hear lots about coronavirus treatment with monoclonal antibodies. There are many of them. What is the big deal? Casirivimab and imdevimab are two monoclonal antibodies synthesized by the pharmaceutical company Regeneron, brand-named REGEN-COV. These dual proteins are a monoclonal antibodies intervention […]
